IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▲ 0.45% USD/MXN18.52▼ 0.42% USD/CLP994.16▼ 0.13% USD/COP3,302▲ 0.70% USD/PEN3.40▼ 0.16% USD/ARS1,544▼ 0.11% USD/UYU40.59▲ 2.33% USD/PYG6,196▲ 2.33% USD/BOB11.59▼ 0.37% USD/DOP60.59▲ 1.85% USD/CRC442.74▼ 0.10% USD/GTQ7.64▲ 2.06% USD/HNL26.91▲ 2.15% USD/NIO 36.62 — 0.00% USD/VES909.35▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 1.39% USD/TTD6.75▲ 1.58% EUR/BRL6.25▲ 0.93% BRENT 95.84 ▲ 0.02% WTI 88.56 ▼ 0.20% IRON ORE 161.91 — — COPPER 6.09 ▼ 1.50% GOLD 3,886 ▲ 0.03% SILVER 49.12 ▼ 1.70% SOY 1,232 ▲ 0.37% CORN 445.50 ▲ 0.68% WHEAT 593.25 ▲ 1.54% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 79.02 ▲ 0.44% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 ▲ 1.34% VALE3 63.50 ▼ 0.70% ITUB4 42.27 ▲ 1.42% BBDC4 14.52 ▲ 1.40% ABEV3 15.79 ▲ 0.25% BBAS3 15.10 ▼ 2.45% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 ▼ 2.27% RENT3 30.07 ▲ 1.66% AZZA3 15.91 ▼ 5.86% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 ▼ 1.63% RANI3 8.18 — 0.00% CSNA3 3.72 ▼ 12.06% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▲ 0.45% USD/MXN 18.52 ▼ 0.42% USD/CLP 994.16 ▼ 0.13% USD/COP 3,302 ▲ 0.70% USD/PEN 3.40 ▼ 0.16% USD/ARS 1,544 ▼ 0.11% USD/UYU 40.59 ▲ 2.33% USD/PYG 6,196 ▲ 2.33% USD/BOB 11.59 ▼ 0.37% USD/DOP 60.59 ▲ 1.85% USD/CRC 442.74 ▼ 0.10% USD/GTQ 7.64 ▲ 2.06% USD/HNL 26.91 ▲ 2.15% USD/NIO 36.62 — 0.00% USD/VES 909.35 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 1.39% USD/TTD 6.75 ▲ 1.58% EUR/BRL 6.25 ▲ 0.93% BRENT 95.84 ▲ 0.02% WTI 88.56 ▼ 0.20% IRON ORE 161.91 — — COPPER 6.09 ▼ 1.50% GOLD 3,886 ▲ 0.03% SILVER 49.12 ▼ 1.70% SOY 1,232 ▲ 0.37% CORN 445.50 ▲ 0.68% WHEAT 593.25 ▲ 1.54% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 79.02 ▲ 0.44% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 ▲ 1.34% VALE3 63.50 ▼ 0.70% ITUB4 42.27 ▲ 1.42% BBDC4 14.52 ▲ 1.40% ABEV3 15.79 ▲ 0.25% BBAS3 15.10 ▼ 2.45% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 ▼ 2.27% RENT3 30.07 ▲ 1.66% AZZA3 15.91 ▼ 5.86% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 ▼ 1.63% RANI3 8.18 — 0.00% CSNA3 3.72 ▼ 12.06%
since 2009
Sunday, November 15, 2026

Goldman Sachs Sees Value in Hapvida After 18% Stock Drop

By · · 2 min read

In the volatile stock market, significant price drops usually alarm investors, but according to Goldman, Hapvida remains an exception.

Goldman Sachs views the 18% drop in Hapvida, a top Brazilian healthcare provider, since May 20 as an ideal buying chance.

This advice follows the company’s strategic merger with NotreDame, marking a pivotal moment promising operational advancements.

Free daily brief — no card needed
Get every Market Reports story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Analysts suggest that recent declines in Brazilian stocks, reflected by Hapvida’s dip and broader economic shifts, create an investment window.

These trends reflect not only local economic pressures but also a reaction to rising future rates across Brazil’s financial landscape.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

Nonetheless, this situation has carved out what Goldman describes as an attractive valuation phase for Hapvida.

Goldman Sachs Sees Value in Hapvida After 18% Stock Drop.
Goldman Sachs Sees Value in Hapvida After 18% Stock Drop.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

The investment giant has pegged the stock’s appeal at a compelling 10 times its adjusted Price/Earnings ratio projected for the close of 2025.

This assessment relies on the idea that despite short-term earnings instability and membership growth challenges, the company’s fundamentals are strong.

The market currently prices Hapvida’s medical loss ratio (MLR) at 70.2% for 2025, slightly higher than expected.

Goldman Sachs Sees Value in Hapvida After 18% Stock Drop

Goldman’s analysts consider the estimate high, citing enhanced service integration and price hikes as grounds for their optimism.

Such strategies are expected to stabilize and possibly improve financial outcomes.

Purchasing shares now could yield a real internal rate of return of 14%, Goldman projects.

This potential gain stands well above the risk-free rate linked to inflation, surpassing it by 800 basis points.

Thus, the narrative woven around Hapvida’s current predicament is not just about overcoming adversity, but about seizing a moment ripe with potential.

For investors, this presents not just a test of nerve but an opportunity to back a healthcare titan poised for recovery and growth.

Live Company IntelligenceHapvida Participações e Investimentos S.A. — the full investor dossierCompany overview and the latest Rio Times coverage.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Read More from The Rio Times

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.